Vitrolife AB (publ)
Stockholm Stock Exchange VITR.ST
Vitrolife AB (publ) Price to Book Ratio (P/B) on January 14, 2025: 1.97
-
Vitrolife AB (publ) 52-week high Price to Book Ratio (P/B) is 2.75 on September 10, 2024, which is 39.71% above the current Price to Book Ratio (P/B).
-
Vitrolife AB (publ) 52-week low Price to Book Ratio (P/B) is 1.55 on April 25, 2024, which is -21.08% below the current Price to Book Ratio (P/B).
-
Vitrolife AB (publ) average Price to Book Ratio (P/B) for the last 52 weeks is 2.08.
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
| CEO | Ms. Bronwyn Brophy O´Connor |
| IPO Date | June 28, 2001 |
| Location | Sweden |
| Headquarters | Gustaf Werners gata 2 |
| Employees | 1,111 |
| Sector | Health Care |
| Industries | |
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email